Cision PR Newswire

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Robust neutralizing antibody responses across RSV, hMPV and PIV3 in Phase 2 recapitulates Phase...

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock...

FDI World Dental Federation launches Generation Smile, the oral health movement for all

Generation Smile is a generation unlike any other. It isn't defined by the year...

China Xplained | The China Squeeze, or the China Opportunity?

GUANGZHOU, China, Sept. 6, 2026 /PRNewswire/ -- This is a news report from South: ...

Education Cannot Wait Welcomes Sigrid Kaag of The Netherlands as New Chair of its High-Level Steering Group

The visionary advocate for children's rights will lead ECW's global efforts to mobilize more resources to ensure children living on the frontlines of the world's...

The groundbreaking ceremony for EPG’s second factory in Malaysia was held

The China-Malaysia governments and enterprises collaboratively creating a new road roadmap for smart manufacturing in Southeast Asia JOHOR BAHRU, Malaysia, April 2, 2025...